TaxTMI Login
Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
When case Id is present, search is done only for this
of 
of 
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
of of 
All Case Laws
of of All Case Laws
Note
Bookmark
Share
Don't have an account? Register Here
of <h1>Classification of 'diagnostic and laboratory reagents' under Customs Tariff Act for GST clarified by Authority for Advance Rulings</h1> <h3>In Re: M/s. Bio-Rad Laboratories India Ltd.,</h3> In Re: M/s. Bio-Rad Laboratories India Ltd., - 2022 (59) G.S.T.L. 288 (A. A. R. - GST - Kar.) Issues Involved:1. Classification of 'diagnostic and laboratory reagents' under the Customs Tariff Act, 1975.2. Applicability of Entry No. 80 of Schedule II to Notification No.1/2017-Integrated Tax (Rate) dated 28.06.2017.3. Determination of the correct GST rate for these reagents.Issue-wise Detailed Analysis:1. Classification of 'diagnostic and laboratory reagents' under the Customs Tariff Act, 1975:The applicant is engaged in the business of importing and selling medical and laboratory instruments, laboratory reagents, and diagnostic reagents classified under tariff heading 3822. The applicant asserts that these reagents fall under Entry No. 80 of Schedule II to Notification No.1/2017-Integrated Tax (Rate) dated 28.06.2017, which prescribes a GST rate of 12%.2. Applicability of Entry No. 80 of Schedule II to Notification No.1/2017-Integrated Tax (Rate) dated 28.06.2017:The applicant argues that Entry No. 80 of Schedule II covers all types of reagents classifiable under Chapter Heading 3822. The explanation provided in Notification No. 01/2017 clarifies that the heading under the Customs Tariff Act, 1975 is relevant for GST purposes as well. The applicant emphasizes that the heading 3822 is broad and encompasses both diagnostic and laboratory reagents without any bifurcation. The applicant also points out that the term 'reagents' in Entry No. 80 is used in a conjunctive sense with 'diagnostic kits,' indicating that all reagents under heading 3822 should be covered.3. Determination of the correct GST rate for these reagents:The applicant supports their view by citing various judicial precedents and legislative intent. They reference the Fitment Committee's recommendations, which suggested a 12% GST rate for all diagnostic and laboratory reagents under heading 3822. This recommendation was adopted in the 16th GST Council Meeting and reflected in the GST Rate Notification issued on 28 June 2017. The applicant also cites several rulings by Advance Ruling Authorities and the Karnataka Appellate Authority for Advance Ruling, which support their interpretation that all reagents under heading 3822 should be taxed at 12%.Findings and Discussion:The Authority for Advance Rulings examined the submissions and relevant facts. They noted that the CBIC issued Circular No. 163/19/2021-GST dated 6th October 2021, which clarified that the intention of Entry No. 80 of Schedule II of Notification No.1/2017-Integrated Tax (Rate) was to prescribe a 12% GST rate for all goods, whether diagnostic or laboratory reagents, falling under heading 3822.Ruling:The Authority concluded that the 'diagnostic and laboratory reagents' imported and supplied by the applicant, classified under heading 3822 of the Customs Tariff Act, 1975, are covered under Entry No. 80 of Schedule II to Notification No.1/2017-Integrated Tax (Rate) dated 28.06.2017. Therefore, these reagents attract a levy of Integrated Tax at the rate of 12%, as clarified in Circular No. 163/19/2021-GST dated 6th October 2021.
TaxTMI 
TaxTMI 
